ALLERGY & IMMUNOLOGY INFORMATION CENTER

News

Gardasil 9 Approved for Use in Women and Men 27 Through 45 Years Old

Gardasil 9 Approved for Use in Women and Men 27 Through 45 Years Old

The approval of the expanded age range was based on data from a clinical trial which evaluated the efficacy of Gardasil (quadrivalent human papillomavirus recombinant vaccine) in 3253 women 27-45 years of age with a median duration of follow-up of 3.5 years post-dose 3.

More Than 14 Million Preteens Need to Receive HPV Vaccine

14 million need to receive two doses of vaccine to reach goal of 80% vaccination by 2026.

Variations in Influenza Vaccination Coverage Among Healthcare Employees Reported

Wide variations in influenza vaccine coverage have been noted across healthcare personnel based on occupation and worksite.

Opinion

The flu shot remains a vital healthcare tool

Even if the flu shot "misses," as it did last year, it remains one of the best tools we have to help our patients live healthier lives.

Communicating vaccine safety to parents

Clinicians should inform parents about the safety of vaccines to encourage them to vaccinate their children.

Adolescents need HPV shots early

Common reasons that parents give when declining human papillomavirus vaccine for their children are, "My teen is not sexually active," or "Maybe we'll wait until he/she is a bit older." This thinking negates the vaccine's preventive purpose.

Features

Platform Manufacturing May Speed Pandemic Vaccine Development

Platform Manufacturing May Speed Pandemic Vaccine Development

With the advent of platform manufacturing technology, vaccines can be developed quickly to stop the spread of outbreaks.

The race to develop a universal influenza vaccine

The race to develop a universal influenza vaccine

NIH's National Institute of Allergy and Infectious Diseases is researching ways to develop a universal influenza vaccine against multiple strains.

Slideshows

Nonallergic rhinitis: What clinicians should know

Nonallergic rhinitis: What clinicians should know

Clinicians must maintain a high degree of suspicion for nonallergic rhinitis to ensure a proper diagnosis and should not rule ...

Sign Up for Free e-newsletters